According to new study by WHO and University College London resistance to antiretroviral drugs, a worrying sign for the course of AIDS epidemic is that it is increasing.

INSTRUCTIONS:

According to new study by WHO and University College London resistance to antiretroviral drugs, a worrying sign for the course of AIDS epidemic is that it is increasing. In parts of Africa,Asia, Latin America, and Caribbean saying that the aforementioned drug resistance was serious only in eastern and southern Africa and was involving, mostly, a class of non-nucleoside reverse transcriptase inhibitors the most common are nevirapine and efavirenz which is sold as Viramune and Sustiva. Seven and fourth tenths percent of viral stain tested eight years after affordable generic AIDS drugs were introduced in east Africa were drugrestisant but in the hardest hit part of the world in southern Africa that percentage were three and zero tenths thus causing that researchers conclude this is not unexpected because nearly eight million people have received the drugs in the past decade. This is still worrisome with generic manufacturers making some modern AIDS drugs with less side effects but only in fewer classes so they can keep their newest inventions at high prices resulting in higher profits. The new report it is suggested that pharmaceutical supply chains be strengthened in order that shortages which are common problem in poor countries will be presented and they also called for better patient tracking when they are prescribed for the drugs because anyone who stops even briefly the therapy are lots more likely to develop a drugrestant stain.

CONTENT:

Name Course:

Tutor:

Date:

AIDS Drugs

Abstract

AIDS remains a killer disease and has been declared a national disaster in many countries. This sad state of affairs made scientists go back to the drawing board to find a lasting solution to the problem. The presence of AIDS drugs referred to as antiretroviral drugs came as a relieve to many and would save the world from a deadly disease. However, a study by the WHO and the University College London indicated some bad news. The resistances to the drugs remain a worrying trend and continue to increase in parts of Africa, Asia, Latin America and Caribbean. Scientists have discovered that this is common in the eastern and southern African regions; indeed the class of drug that was found wanting is in the class of non-nucleoside reverse transcriptase inhibitors the most common are nevirapine and efavirenz which is sold as Viramune and Sustiva.

100% Plagiarism Free & Custom Written, Tailored to your instructions